Department of Pediatrics, Minoh City Hospital, 5-7-1 Kayano, Minoh City, Osaka, 562-8562, Japan.
Department of Pediatric Nephrology and Metabolism, Osaka Women's and Children's Hospital, 840 Murodo, Izumi City, Osaka, 594-1101, Japan.
CEN Case Rep. 2020 May;9(2):95-100. doi: 10.1007/s13730-019-00434-z. Epub 2019 Nov 9.
The oculocerebrorenal disorder of Lowe syndrome is an X-linked mutation in the gene oculocerebrorenal syndrome of Lowe 1 (OCRL), characterized by the triad of congenital cataracts, severe intellectual impairment, and renal tubular dysfunction. Manifestations of phenotype in female carriers and patients are extremely rare. We present a female case with congenital cataracts, severe intellectual impairment, sensorineural hearing loss, and renal tubular dysfunction as Lowe syndrome. A 9-year-old Japanese girl visited our hospital due to prolonged proteinuria. Her renal biopsy revealed diffuse mesangium proliferation, sclerosis and dilatation of renal tubules, and mild IgA deposition in the mesangial region. Furthermore, she had congenital cataracts, severe intellectual impairment, and sensorineural hearing loss. Genetic screening did not identify mutations of the ORCL gene encoding inositol polyphosphate 5-phosphatase (IPP-5P) (46 XX, female). However, we found the reduction of enzyme activity of IPP-5P to 50% of the normal value. Furthermore, her renal function had deteriorated to renal failure within a decade. Finally, she received peritoneal dialysis and renal transplantation. We present the oculocerebrorenal phenotype of Lowe syndrome in a female patient with reduced activity of IPP-5P without OCRL gene mutation.
Lowe 综合征的眼-脑-肾病变是 Lowe1 型眼脑肾综合征基因(OCRL)的 X 连锁突变,其特征为先天性白内障、严重智力障碍和肾小管功能障碍三联征。女性携带者和患者的表型表现极为罕见。我们报告了一例女性病例,其表现为先天性白内障、严重智力障碍、感觉神经性听力损失和肾小管功能障碍,符合 Lowe 综合征的诊断。一名 9 岁的日本女孩因持续性蛋白尿来我院就诊。她的肾活检显示弥漫性系膜增殖、硬化和肾小管扩张,系膜区有轻度 IgA 沉积。此外,她还患有先天性白内障、严重智力障碍和感觉神经性听力损失。基因筛查未发现编码肌醇多磷酸 5-磷酸酶(IPP-5P)(46 XX,女性)的 ORCL 基因突变。然而,我们发现 IPP-5P 的酶活性降低至正常值的 50%。此外,她的肾功能在十年内已恶化至肾衰竭。最终,她接受了腹膜透析和肾移植。我们报告了一例女性 Lowe 综合征患者,其 IPP-5P 活性降低但无 OCRL 基因突变,表现出眼-脑-肾病变表型。